🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

11779+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Showing 20 of 11779 recruiting trials

Phase 2RecruitingNCT06648889

Isatuximab in Adult Patients With Cytologic or Molecular Relapsed/Refractory CD38 Positive T-cell Acute Lymphoblastic Leukemia

👨‍⚕️ Nicola Goekbuget, MD, Department of Medicine, Hematology and Oncology, Goethe University Frankfurt, Frankfurt, Germany📍 14 sites📅 Started Oct 2024View details ↗
RecruitingNCT06777914

Familial Intrahepatic Cholestasis-related Genes Associated with Disease Susceptibility in Hepato-biliary Cancers

👨‍⚕️ Giovanni Vitale, MD, IRCCS Azienda Ospedaliero-Universitaria di Bologna📍 5 sites📅 Started Oct 2024View details ↗
Phase 3RecruitingNCT06250257

Bromocriptine in Dilated Cardiomyopathy Among Women of Reproductive Age

👨‍⚕️ Kedir N Tukeni, MD, Jimma University📍 1 site📅 Started Oct 2024View details ↗
Phase 3RecruitingNCT06623422

A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)

👨‍⚕️ Medical Director, Merck Sharp & Dohme LLC📍 231 sites📅 Started Oct 2024View details ↗
RecruitingNCT06480526

Feasibility of Screening for Early Late Effects of Contemporary Therapy in High-Risk Neuroblastoma Survivors

👨‍⚕️ Sara Federico, MD, St. Jude Children's Research Hospital📍 1 site📅 Started Oct 2024View details ↗
RecruitingNCT06785597

EpigenOMic Determinants of the Neuroendocrine Phenotype As Biomarkers for Neuroendocrine Neoplasms

👨‍⚕️ Nicola Fazio, MD, European Institute of Oncology📍 1 site📅 Started Oct 2024View details ↗
NARecruitingNCT06607705

Changes in Eye Pressure in Glaucoma Patients Treated with Istent Inject W, Monitored by a Contact Lens Sensor

🏥 Fundacio Privada Mon Clinic Barcelona📍 2 sites📅 Started Oct 2024View details ↗
RecruitingNCT06930417

Characterization and Natural History of Williams Syndrome and Other Chromosome 7q11.23 Variants

👨‍⚕️ Daniel Rader, MD, University of Pennsylvania📍 1 site📅 Started Oct 2024View details ↗
Enrolling by InvitationNCT06844331

Ultrasound Applicability in the Assessment of Patients With Fibrosing Interstitial Lung Disease

👨‍⚕️ Jesper R Davidsen, MD,PhD, Department of Respiratory Medicine, Odense University Hospital📍 1 site📅 Started Oct 2024View details ↗
Phase 1, PHASE2RecruitingNCT06730009

Phase I/II Study: Allogeneic NK-cell Therapy With Chemotherapy for Post-Surgery PDA or Cholangiocarcinoma Patients

👨‍⚕️ Stanley Chang, PhD, Medigen Biotechnology Corporation📍 1 site📅 Started Oct 2024View details ↗
RecruitingNCT07254312

Correlation of Venetoclax Plasma Concentrations With Toxicity of Hypometilating Agents and Venetoclax Combination for Acute Myeloid Leukemia Patients in Remission.

🏥 Fondazione IRCCS Policlinico San Matteo di Pavia📍 1 site📅 Started Oct 2024View details ↗
Phase 2RecruitingNCT06651853

Large Fraction Radiation Therapy Combined With Lenalidomide, and Glofitamab in Refractory Relapsed DLBCL

🏥 The First Affiliated Hospital of Xiamen University📍 1 site📅 Started Oct 2024View details ↗
NARecruitingNCT06618638

Shared Decision Making for Choosing Autosomal DOminant Polycystic Kidney Disease Treatment

👨‍⚕️ Yong Chul Kim, Seoul National University Hospital📍 9 sites📅 Started Oct 2024View details ↗
Phase 3RecruitingNCT06205095

A Pilot Crossover Trial of Prophylactic Wilate Compared to Placebo for Heavy Menstrual Bleeding in Patients with VWD

🏥 Unity Health Toronto📍 1 site📅 Started Oct 2024View details ↗
Phase 1, PHASE2RecruitingNCT06640582

TIL Therapy Combined With Pembrolizumab for Advanced Brain Cancer Including Gliomas and Meningiomas

🏥 Essen Biotech📍 1 site📅 Started Oct 2024View details ↗
RecruitingNCT06646250

NeoDoppler: New Ultrasound Technology for Continuous Monitoring of Cerebral Circulation Pilot

👨‍⚕️ Siri Ann Nyrnes, MD, PhD, Childrens Clinic, St. Olavs University Hospital and NTNU📍 1 site📅 Started Oct 2024View details ↗
EARLY_Phase 1RecruitingNCT06633354

Targeting CD5 CAR-T Cells in the Treatment of r/r CD5+ T-ALL

👨‍⚕️ He Huang, MD, First Affiliated Hospital of Zhejiang University📍 1 site📅 Started Oct 2024View details ↗
Phase 1RecruitingNCT06554301

A Study on the Efficacy and Safety of Empagliflozin in the Treatment of Pulmonary Arterial Hypertension

🏥 China National Center for Cardiovascular Diseases📍 1 site📅 Started Oct 2024View details ↗
Phase 2RecruitingNCT06257394

Treatment of Pediatric Very High-risk Acute Lymphoblastic Leukemia in Korea

🏥 Hyoung Jin Kang📍 6 sites📅 Started Oct 2024View details ↗
Phase 1, PHASE2RecruitingNCT06288230

An Open Label Study of Gene Therapy Product (Vesemnogene Lantuparvovec) in Spinal Muscular Atrophy

🏥 Lantu Biopharma📍 1 site📅 Started Oct 2024View details ↗
← PreviousPage 221 of 589Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →